Page 84 - Biennial Report 2018-20 Jun 2021

an efficient suppression of Ehrlich ascites tumors.” Drug Deliv. Transl. Res. 2018 Jun, 8:
565.
23. Shivangi, Meena LS. “A Novel Approach in Treatment of Tuberculosis by Targeting Drugs
to Infected Macrophages Using Biodegradable Nanoparticles.” APPL BIOCHEM BIOTECH
2018 Jul;185(3):815-821.

24. Prakash J, Sharma R, Patel SKS, Kim IW, Kalia VC. “Bio-hydrogen production by co-
digestion of domestic wastewater and biodiesel industry effluent.” PLoS One 2018 Jul
11;13(7):e0199059.

25. Jaisinghani N, Dawa S, Singh K, Nandy A, Menon D, Bhandari PD, Khare G, Tyagi A,
Gandotra S. “Necrosis Driven Triglyceride Synthesis Primes Macrophages for
Inflammation During Mycobacterium tuberculosis Infection.” Front Immunol 2018 Jul
3;9:1490.

26. Tripathi V, Priya S, Dhapola P, Saha D, Madhavan V, Chowdhury S, Sengupta S. “BLM
Potentiates c-Jun Degradation and Alters Its Function as an Oncogenic Transcription
Factor.” Cell Reports 2018 Jul 24;24(4):947-961.e7.

27. Kumari R, Kumar D, Brahmachari SK, Srivastava AK, Faruq M, Mukerji M. “Paradigm for
disease deconvolution in rare neurodegenerative disorders in Indian population: insights
from studies in cerebellar ataxias.” J GENET 2018 Jul;97(3):589-609.
28. Rawat C, Guin D, Talwar P, Grover S, Baghel R, Kushwaha S, Sharma S, Agarwal R, Bala K,
Srivastava AK, Kukreti R. “Clinical predictors of treatment outcome in North Indian
patients on antiepileptic drug therapy: A prospective observational study.” NEUROL
INDIA 2018 Jul-Aug;66(4):1052-1059.
29. Vellarikkal SK, Jayarajan R, Verma A, Ravi R, Senthilvel V, Kumar A, Saini L, Gulati S, Lal
M, Mathur A, Chhetri MK, Faruq M, Scaria V, Sivasubbu S. “A founder mutation MLC1
c.736delA associated with megalencephalic leukoencephalopathy with subcortical cysts-
1 in north Indian kindred.” CLINICAL GENETICS 2018 Aug;94(2):271-273.
30. Bothra A, Arumugam P, Panchal V, Menon D, Srivastava S, Shankaran D, Nandy A,
Jaisinghani N, Singh A, Gokhale RS, Gandotra S, Rao V. “Phospholipid homeostasis,
membrane tenacity and survival of Mtb in lipid rich conditions is determined by MmpL11
function.” Sci Rep 2018 Aug (8), 8317.
31. Meena S, Shivangi and Meena LS. “Interaction of Mycobacterium tuberculosis H37Rv
with Microfold Cell leads to a New Era of infection in Host (Review Article).” ANNALS OF
CLINICAL AND LABORATORY 2018 Aug, Vol.6 No.3:246.
32. Jain P, Malakar B, Khan MZ, Lochab S, Singh A and Nandicoori VK. “Delineating FtsQ
mediated regulation of cell division in Mycobacterium tuberculosis.” J BIOL CHEM 2018
Aug 10;293(32):12331-12349.
33. Basu S, Jalodia K, Ranjan S, Yeh JJ, Peterson RT, Sachidanandan C. “Small Molecule
Inhibitors of NFkB Reverse Iron Overload and Hepcidin Deregulation in a Zebrafish Model
for Hereditary Hemochromatosis Type 3.” ACS CHEM BIOL 2018 Aug 17;13(8):2143-
2152.

83